FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that ...
In addition to the commonly known A, B, AB and O blood types, hundreds of blood group antigens exist on red blood cells that differ between individuals. These particles can activate the body’s immune ...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that ...
In the developed world, most of the reported complications of transfusion have an immunological basis. Although the media and the public are worried about the infectious risks of transfusion, ...
BATON ROUGE, La. (WAFB) - There’s a treatment that doctors are giving to COVID-19 patients who are at high risk to help prevent virus from getting worse. Allen Schlenberg contracted COVID-19 in late ...
An ongoing, phase 3, open-label study demonstrated the efficacy of exagamglogene autotemcel (exa-cel) infusion to promote transfusion dependence in patients with transfusion-dependent β-thalassemia ...
Since November 2015, Puerto Rico has reported active mosquito-borne transmission of Zika virus. [1] Because of the potential for Zika virus to be transmitted through transfusion of blood components, ...
TDT is a serious, life-threatening genetic disease. TDT patients report health-related quality of life scores below the general population and significant health care resource utilization. TDT ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback